Boston Jury Awards Teva Pharmaceuticals $176.5M for Eli Lilly's Migraine Medication Patent Infringement
“We are disappointed with the jury’s verdict and we remain confident that Lilly will ultimately prevail in this case,” Lilly spokeswoman Daphne Dorsey told Law.com. “Importantly, this decision has no effect on our ability to make Emgality available to patients.”
CEO of Speaker Media and Marketing, is the "Secret Weapon of Personal Injury Lawyers and Trial Attorneys" throughout the United States. Specializing as a marketing consultant to lawyers, with a primary focus on content marketing, social media, online video and mobile marketing strategies.
Click Here To Read The Full Article